Anti-IL-6 抗体 [EPR21711]
Anti-IL-6 antibody [EPR21711]
- 20ul selling size
- RabMAb
- Recombinant
- KO Validated
- 詳細を見る
5
(1 Review)
|
(131 Publications)
Anti-IL-6 antibody [EPR21711] (ab233706) is a rabbit monoclonal antibody detecting IL-6 in Western Blot, Flow Cytometry (Intra), IP, ICC/IF. Suitable for Human.
- KO validated for confirmed specificity
- Biophysical QC for unrivalled batch-batch consistency
- Over 60 publications
別名を表示する
IFNB2, IL6, Interleukin-6, IL-6, B-cell stimulatory factor 2, CTL differentiation factor, Hybridoma growth factor, Interferon beta-2, BSF-2, CDF, IFN-beta-2
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-IL-6 antibody [EPR21711] (AB233706)
Immunofluorescent analysis of 4% paraformaldehyde-fixed, 0.1% Triton X-100 permeabilized HUVEC (human umbilical vein endothelial cell line) cells labeling IL6 with ab233706 at 1/50 dilution, followed by Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution (green). Confocal image showing cytoplasmic staining in HUVEC cells treated with lipopolysaccharide (0.5 μg/ml) for 24h and Brefeldin A (300 ng/ml) for 20h. The nuclear counterstain is DAPI (blue). Tubulin is detected with Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) (ab195889) at 1/200 dilution (red).
Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution.
- Flow Cyt (Intra)
Supplier Data
Flow Cytometry (Intracellular) - Anti-IL-6 antibody [EPR21711] (AB233706)
Intracellular flow cytometric analysis of 4% paraformaldehyde-fixed, 90% methanol-permeabilized HUVEC (human umbilical vein endothelial cell line) treated with lipopolysaccharide (0.5 μg/ml) for 24h and Brefeldin A (300 ng/ml) for 20h (red) / untreated control (green) cells labeling IL6 with ab233706 at 1/500 compared with a Rabbit monoclonal IgG (ab172730) (black) and an unlabeled control (cells without incubation with primary antibody and secondary antibody) (blue). Goat anti rabbit IgG (Alexa Fluor® 488, ab150077), at 1/2000 dilution was used as the secondary antibody.
- IP
Supplier Data
Immunoprecipitation - Anti-IL-6 antibody [EPR21711] (AB233706)
IL6 was immunoprecipitated from 0.35 mg HUVEC (human umbilical vein endothelial cell line) treated with lipopolysaccharide (0.5 μg/ml) for 24h and Brefeldin A (300 ng/ml) for 20h, whole cell lysate with ab233706 at 1/30 dilution. Western blot was performed from the immunoprecipitate using ab233706 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/10000 dilution.
Lane 1 : HUVEC treated with lipopolysaccharide (0.5 μg/ml) for 24h and Brefeldin A (300 ng/ml) for 20h, whole cell lysate 10 μg (Input).
Lane 2 : ab233706 IP in HUVEC treated with lipopolysaccharide (0.5 μg/ml) for 24h and Brefeldin A (300 ng/ml) for 20h, whole cell lysate.
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab233706 in HUVEC treated with lipopolysaccharide (0.5 μg/ml) for 24h and Brefeldin A (300 ng/ml) for 20h, whole cell lysate.
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 5 seconds.
All lanes:
Immunoprecipitation - Anti-IL-6 antibody [EPR21711] (ab233706)
Predicted band size: 23 kDa
false
- WB
Lab
Western blot - Anti-IL-6 antibody [EPR21711] (AB233706)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) staining at 1/1000000 dilution.
In Western blot analysis, ab233706 exhibited lower sensitivity compared to ab233551, for which reason we recommend the latter one as superior alternative.
ab233706 does not work in THP-1 cell line due to sensitivity issue.
Lanes 1 - 2:
Western blot - Anti-IL-6 antibody [EPR21711] (ab233706) at 1/1000 dilution
Lanes 3 - 4:
Western blot - Anti-IL-6 antibody [EPR22565-204] (<a href='/products/primary-antibodies/il-6-antibody-epr22565-204-ab233551'>ab233551</a>) at 1/1000 dilution
Lanes 1 and 3:
Untreated HUVEC (human umbilical vein endothelial cell line) whole cell lysate at 20 µg
Lanes 2 and 4:
HUVEC treated with 0.5 ug/ml lipopolysaccharides (LPS) for 24 hours, added 300 ng/ml BFA last 20 hours whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 23 kDa
false
Exposure time: 20s
- WB
Lab
Western blot - Anti-IL-6 antibody [EPR21711] (AB233706)
Lanes 1 - 4 : Merged signal (red and green). Green - ab233706 observed at 25 kDa. Red - loading control ab7291 (Mouse anti-Alpha Tubulin [DM1A] observed at 55kDa.
ab233706 was shown to react with IL-6 in wild-type A549 cells in western blot with loss of signal observed in IL-6 knockout cell line ab273751 (knockout cell lysate ab275501). Wild-type and IL-6 knockout A549 cell lysates were subjected to SDS-PAGE. Membranes were blocked in fluorescent western blot (TBS-based) blocking solution before incubation with ab233706 and ab7291 (Mouse anti-Alpha Tubulin [DM1A] overnight at 4°C at a 1 in 1000 Dilution and a 1 in 20000 dilution respectively. Blots were incubated with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-IL-6 antibody [EPR21711] (ab233706) at 1/1000 dilution
Lane 1:
Wild-type A549 Brefeldin A (<a href='/products/biochemicals/brefeldin-a-inhibitor-of-adp-ribosylation-factor-ab120299'>ab120299</a>)-treated (5ug/ml, 4h) cell lysate at 30 µg
Lane 2:
Wild-type A549 IL-1β (<a href='/products/proteins-peptides/recombinant-human-il-1-beta-protein-active-ab259387'>ab259387</a>) (20 ng/ml, 24h) and Brefeldin A (<a href='/products/biochemicals/brefeldin-a-inhibitor-of-adp-ribosylation-factor-ab120299'>ab120299</a>)-treated (5 ug/ml for the last 4h) cell lysate at 30 µg
Lane 2:
Western blot - Human IL-6 knockout A549 cell line (<a href='/products/cell-lines/human-il-6-knockout-a549-cell-line-ab273751'>ab273751</a>)
Lane 3:
IL-6 knockout A549 Brefeldin A (<a href='/products/biochemicals/brefeldin-a-inhibitor-of-adp-ribosylation-factor-ab120299'>ab120299</a>)-treated (5ug/ml, 4h) cell lysate at 30 µg
Lane 4:
IL-6 knockout A549 IL-1β (<a href='/products/proteins-peptides/recombinant-human-il-1-beta-protein-active-ab259387'>ab259387</a>) (20 ng/ml, 24h) and Brefeldin A (<a href='/products/biochemicals/brefeldin-a-inhibitor-of-adp-ribosylation-factor-ab120299'>ab120299</a>)-treated (5 ug/ml for the last 4h) cell lysate at 30 µg
Predicted band size: 23 kDa
Observed band size: 25 kDa,35 kDa,40 kDa
false
- WB
Lab
Western blot - Anti-IL-6 antibody [EPR21711] (AB233706)
Lanes 1 - 4 : Merged signal (red and green). Green - ab233706 observed at 25 kDa. Red - loading control ab7291 (Mouse anti-Alpha Tubulin [DM1A] observed at 55kDa.
ab233706 was shown to react with IL-6 in wild-type A549 cells in western blot with loss of signal observed in IL-6 knockout cell line ab273751 (knockout cell lysate ab275501). Wild-type and IL-6 knockout A549 cell lysates were subjected to SDS-PAGE. Membranes were blocked in fluorescent western blot (TBS-based) blocking solution before incubation with ab233706 and ab7291 (Mouse anti-Alpha Tubulin [DM1A] overnight at 4°C at a 1 in 1000 Dilution and a 1 in 20000 dilution respectively. Blots were incubated with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-IL-6 antibody [EPR21711] (ab233706) at 1/1000 dilution
Lane 1:
Wild-type A549 Brefeldin A (<a href='/products/biochemicals/brefeldin-a-inhibitor-of-adp-ribosylation-factor-ab120299'>ab120299</a>)-treated (5ug/ml, 4h) cell lysate at 30 µg
Lane 2:
Wild-type A549 IL-1β (<a href='/products/proteins-peptides/recombinant-human-il-1-beta-protein-active-ab259387'>ab259387</a>) (20 ng/ml, 24h) and Brefeldin A (<a href='/products/biochemicals/brefeldin-a-inhibitor-of-adp-ribosylation-factor-ab120299'>ab120299</a>)-treated (5 ug/ml for the last 4h) cell lysate at 30 µg
Lane 3:
IL-6 knockout A549 Brefeldin A (<a href='/products/biochemicals/brefeldin-a-inhibitor-of-adp-ribosylation-factor-ab120299'>ab120299</a>)-treated (5ug/ml, 4h) cell lysate at 30 µg
Lane 4:
IL-6 knockout A549 IL-1β (<a href='/products/proteins-peptides/recombinant-human-il-1-beta-protein-active-ab259387'>ab259387</a>) (20 ng/ml, 24h) and Brefeldin A (<a href='/products/biochemicals/brefeldin-a-inhibitor-of-adp-ribosylation-factor-ab120299'>ab120299</a>)-treated (5 ug/ml for the last 4h) cell lysate at 30 µg
false
関連する標識済み抗体及び組成の異なる製品 (5)
-
Anti-IL-6 antibody [EPR21711] - Low endotoxin, Azide free
-
Anti-IL-6 antibody [EPR21711] - BSA and Azide free
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-IL-6 antibody [EPR21711]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-IL-6 antibody [EPR21711]
-
519 FITC
FITC Anti-IL-6 antibody [EPR21711]
Reactivity data
製品の詳細
Product Specifications
Anti-IL-6 antibody [EPR21711] (ab233706) was developed by Abcam using patented rabbit monoclonal antibody technology and is validated for use in Flow Cyt (Intra), ICC/IF, IP, WB in human samples.
Anti-IL-6 antibody [EPR21711] (ab233706) specifically detects IL-6 (UniProt ID: P05231; Molecular weight: 21kDa) and is sold in 100 µL and 1 mL selling sizes.
Quality and Validation
Abcam's high quality manufacturing and validation processes ensure Anti-IL-6 antibody [EPR21711] (ab233706) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility.
The specificity of Anti-IL-6 antibody [EPR21711] (ab233706) has been confirmed by testing in knockout samples.
Anti-IL-6 antibody [EPR21711] (ab233706) has been cited over 60 times in peer reviewed journals and is trusted by the scientific community.
Related Products
Conjugation-ready, carrier free format available for antibody clone EPR21711 - ab233707.
Antibody clone EPR21711 is also available pre-conjugated to a variety of labels for your convenience - Alexa Fluor® 647, Alexa Fluor® 488, FITC (ab303458, ab314590, ab322292).
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
出荷温度及び保存条件
製品の状態
精製方法
バッファー組成
出荷温度
短期保存期間
短期保存温度
長期保存温度
分注に関する情報
保管に関する情報
補足情報
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
IL-6 influences immune regulation and acts as part of the acute phase response. It stimulates the production of acute-phase proteins and supports the differentiation of B cells into antibody-producing cells. IL-6 is not known to be part of a larger complex acting primarily as a single entity in signal transduction. Moreover IL-6 impacts the metabolism of iron and bone homeostasis showing its multifunctional nature.
Pathways
IL-6 forms an integral part of several signaling routes particularly the JAK-STAT pathway. In this context IL-6 interacts with signal transducer proteins like STAT3 to transmit signals from the cell surface to the nucleus affecting gene expression. Another important pathway is the MAPK pathway through which IL-6 influences cell proliferation and survival. These interactions reflect IL-6's diverse effects in cellular processes.
製品プロトコール
- Visit the General protocols
- Visit the Troubleshooting
ターゲットの情報
文献 (131)
Recent publications for all applications. Explore the full list and refine your search
Pakistan journal of pharmaceutical sciences 38:1577-1588 PubMed40996173
2025
Applications
Unspecified application
Species
Unspecified reactive species
Drug design, development and therapy 19:8097-8114 PubMed40955307
2025
Applications
Unspecified application
Species
Unspecified reactive species
Biomolecules 15: PubMed40563502
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of inflammation (London, England) 22:23 PubMed40537786
2025
Applications
Unspecified application
Species
Unspecified reactive species
International journal of women's health 17:1165-1174 PubMed40308269
2025
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in nutrition 12:1470505 PubMed40206943
2025
Applications
Unspecified application
Species
Unspecified reactive species
Neuroreport 36:350-363 PubMed40203233
2025
Applications
Unspecified application
Species
Unspecified reactive species
Brain sciences 15: PubMed40002461
2025
Applications
Unspecified application
Species
Unspecified reactive species
World journal of clinical oncology 16:97296 PubMed39995553
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of inflammation research 18:1719-1738 PubMed39931165
2025
Applications
Unspecified application
Species
Unspecified reactive species
Abcam product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com